FDA

Robert F. Kennedy Jr. is a vocal opponent of artificial food dyes, blaming them in part for the “chronic disease epidemic" in America. He may get the opportunity to bring major changes to the U.S. food industry under the incoming Trump administration.  What To Know: President-elect...

After years of regulatory delays, the U.S. Food and Drug Administration (FDA) has approved Phase 2 of a clinical trial to assess the efficacy of smoked medical cannabis in treating post-traumatic stress disorder (PTSD) among military veterans. Funded by Michigan's Veteran Marijuana Research Grant...

The U.S. Food and Drug Administration (FDA) has offered positive feedback to CaaMTech, Inc. on its CT-4201 psilocin prodrug program, specifically endorsing the company's approach to addressing "functional unblinding" in its drug trials. This regulatory milestone not only clears the clinical...

President-elect Donald Trump has said he will give Robert F. Kennedy Jr. a senior role in his incoming administration to advance his "Make America Healthy Again" agenda. Trading in pharmaceutical stocks is shaky this week and the details are few surrounding a possible appointment. What To Know:...

Robert Kennedy Jr. has disclosed President-Elect Donald Trump’s three-fold directive to him, aimed at transforming the nation’s health landscape. What Happened: On Wednesday, Kennedy Jr. took to X to share the tasks Trump has assigned to him. He wrote that Trump asked him to do three...

Former President Donald Trump has pledged to give Robert F. Kennedy Jr. full authority over health, food, and medicine issues if he secures a second term. What Happened: Trump revealed his plans on Sunday, expressing his intent to allow Kennedy to have free reign over health, food, and medicine-...

In response to an E. coli outbreak associated with fresh onions, leading U.S. fast-food chains including McDonald’s Corp (NYSE:MCD), Restaurant Brands International (NYSE:QSR), and Yum Brands Inc. (NYSE:YUM) have decided to remove the vegetable from their menus. The outbreak has reportedly...

The Food and Drug Administration (FDA) has launched an investigation into Taylor Farms, a supplier for McDonald's Corporation (NYSE:MCD), after multiple people fell ill with E. coli linked to the restaurant chain's Quarter Pounder. What Happened: According to an NBC News report, Taylor Farms has...

A leading player in psychoactive hemp-derived products (PHDs), LFTD Partners Inc. (OTC:LIFD) is trading at just 0.2x CY24 EV/Sales, offering a steep discount. The stock has plummeted over 90% from its April 2021 peak but remains cash flow positive with a net cash position, leaving the company ripe...

A Food and Drug Administration (FDA) advisory panel overwhelmingly rejected MDMA-assisted therapy for treating post-traumatic stress disorder (PTSD). in early August, citing significant concerns about the treatment and research process. Among the primary issues were design flaws in clinical trials...

The U.S. Food and Drug Administration (FDA) has scheduled a public meeting for September 6, 2024, to gather input on potential new treatments for post-traumatic stress disorder (PTSD), including the use of psychedelic drugs. This meeting marks a significant step in the ongoing exploration of...

Regeneron Pharmaceuticals Inc. (NASDAQ:REGN) has received a setback as the Food and Drug Administration has declined its application for a blood cancer treatment. What Happened: The FDA rejected Regeneron’s application for linvoseltamab, a treatment for a form of blood cancer, the company...

The recent rejection by the Food and Drug Administration (FDA) of an application that would have authorized the use of MDMA for the treatment of post-traumatic stress disorder (PTSD) reignited the already ongoing discussion on psychedelic-assisted therapies. This not only affects the 13 million...

The Food and Drug Administration (FDA) has unexpectedly withdrawn its request for White House permission to conduct a study on the risks associated with kratom and psychedelics. As Marijuana Moment reported, this move comes in response to growing public criticism, particularly from advocates who...

The Food and Drug Administration (FDA) this week declined to approve the use of MDMA — popularly known as Ecstasy or Molly — for MDMA-assisted therapy for treating PTSD, disappointing many Americans who suffer with intractable mental health conditions and had pinned their hopes on the treatment....